[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.173.234.140. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 17, 1978

Botulism and Guanidine: Ten Years Later

Author Affiliations

From the Department of Neurology, University of Colorado Medical Center, Denver.

JAMA. 1978;240(21):2276-2277. doi:10.1001/jama.1978.03290210058027
Abstract

Guanidine hydrochloride was introduced as an adjunct in the treatment of botulism in 1968. It has been reported to be of benefit in 39 cases and of no benefit in 13 cases. No serious side effects have occurred with the short-term therapy required in botulism. Our two cases are similar to earlier cases in that the improvement seen with guanidine therapy is most notable in ocular muscles and least notable in respiratory muscles. Electrophysiological findings again showed an increase in the amplitude of evoked muscle-action potentials after guanidine administration.

(JAMA 240:2276-2277, 1978)

×